Aim To examine the association of radiographic measures of heart size with mortality from coronary heart disease.
Introduction
Aetiological studies of myocardial ischaemia and myocardial infarction have tended to concentrate on factors which influence atherothrombotic processes in the coronary arteries, rather than directly on myocardial pathophysiology[ll. Left ventricular mass and left ventricular systolic dysfunction are among the more important measures of myocardial pathophysiology. Although hypertrophy of the left ventricular myocardium has long been recognised as a strong predictor of coronary heart disease events [21, 
only recently has
See page 826 for the Editorial comment on this article evidence of its independence as a coronary risk factor been available. In patient populations, increased left ventricular mass, determined by echocardiography, is associated with coronary heart disease morbidity and mortality; this effect is independent of both blood pressure [3-7 1 and the number of diseased coronary arteries at angiography , furthermore the effect of raised left ventricular mass is continuous and not confined to those with left ventricular hypertrophy. By contrast with the large number of studies in patient populations, only one population-based studyFramingham -has reported the effect of echocardiographically determined left ventricular mass on incident coronary heart disease events[l21. In this elderly population, increased left ventricular mass predicted coronary heart disease events over a 4-year period of follow-up. It is not known whether left ventricular systolic dysfunction predicts coronary heart disease.
Introduction
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Radiographic measures of heart sizecardiothoracic ratio [13) and relative heart volume [14) are associated with left ventricular mass assessed at post-mortem [9) and at angiography [15) and have been used as proxy measures of left ventricular mass [16, 17) , Cardiothoracic ratio and relative heart volume are also associated with left ventricular systolic dysfunction at angiography [18, 19) , While echocardiographic measures of left ventricular mass and function are the 'gold standard', they are more costly than chest X-rays and there are no long-term follow-up data from population studies, Inclusion of radiographic measures of heart size in the original Whitehall study of British civil servants over 25 years ago offers the advantage of prolonged follow-up, Other studies have reported relationships between relative heart volume [16, [20] [21] [22] , cardiothoracic ratio [16, 23) and cardiovascular mortality, but this is an outcome which includes stroke, heart failure and intermittent claudication as well as coronary heart disease, Since different mechanisms may be involved in linking heart size and each of these diseases, examination specifically of coronary mortality is important. The relative heart volume involves measurements from the lateral as well as the postero-anterior chest X-ray, although previous studies have not examined whether this more detailed measure offers better predictive information than the simpler and routinely used cardiothoracic ratio, The aim therefore of the present investigation was to examine the association of the cardiothoracic ratio and relative heart volume with mortality from coronary heart disease over a 25-year follow-up period in the Whitehall study of British civil servants,
Method
Details of the original Whitehall study have been reported elsewhere [24) , Nineteen thousand and nineteen men aged 40-69 years attended the original screening examination between September 1967 and January 1970, The response rate was 74%, The initial questionnaire covered: Rose angina [25) , previous hospital admissions for coronary heart disease, smoking history, symptoms of chronic bronchitis [26) , shortness of breath ('Do you get short of breath walking with people of your own age on level ground?') and leisure time activities (classified into inactive, moderately active or active), Limb lead electrocardiograms were classified according to the Minnesota code [27) , with ischaemia defined as the presence ofQ waves (codes 1-1 to 1-3), ST abnormalities (4-1 to 4-4), T-wave abnormalities (5-1 to 5-3) or left bundle branch block . Tall R waves (codes 3-1 to 3-3) were used to reflect left ventricular hypertrophy. A single reading of blood pressure was recorded on the left arm with the participant seated. To reduce observer bias and variation, observers were specially trained and used the London School of Hygiene sphygmomanometer. Plasma cholesterol, fasting and 2 h post load glucose, height, Eur Heart J, Vol. 19, June 1998 weight and forced expiratory volume in one second (FEV I), were determined in standardized fashion, described elsewhere [24) .
Chest X-rays
The radiological methods used in the Whitehall study have been described in detail elsewhere [20, 28, 29) . Twelve thousand six hundred and thirty participants had a postero-antero and lateral 100 mm chest radiograph in order to screen for respiratory disease. For technical reasons, satisfactory paired films were not available on the remaining 5773 participants. Films were exposed at full inspiration by a single technician using an Odelca camera. A random 10% sample of 1263 individuals were selected for radiographic measurements. Due to the poor quality of the lateral film, severe scoliosis, thoracoplasties or other severe chest deformities, the cardiothoracic ratio was measured on 1203 films and relative heart volume on 1176. Measurements were made blind to vital status by a single reader. Compared with the participants not in the random sample, the rate ratios for all-cause mortality for those in the random sample and those who did not have paired films were 1·01 (95% CI 0'93-1'11) and 0·99 (95% CI 0·94-1'04) respectively. This excludes a serious selection bias.
The cardiothoracic ratio was calculated as the ratio of the maximal transverse diameter of the cardiac silhouette (,heart diameter') to the distance between the internal margins of the ribs at the level of the right hemidiaphragm (,transverse thoracic diameter'), see Fig. I . The heart volume was calculated using the ellipsoidal approximation technique [14) from the long axis x broad axis x horizontal diameter x (n/6 x 46'52)/ 1000000, where (n/6 x 46'52) is a magnification factor which allows comparison with heart volumes obtained using full size films [28, 30) . This was validated in the study sample against full size films and models. Other studies [21, 31) have reported correlation coefficients of :2: 0·979 between measurements taken from a 100 mm photofluorgraph and those taken from a 14" x 12" chest radiograph; the slope of the relationship between the cardiothoracic ratio measured by the two methods approaches I (i.e. equivalence)l31). The long axis is defined as the distance between the left cardiophrenic junction and the junction of the right heart border with great vessel shadow (aorta or superior vena cava). The broad axis is the distance between the junction of the pulmonary conus and left heart border and the right cardiophrenic junction. The horizontal antero-posterior axis is the greatest distance between the anterior and posterior cardiac borders on the lateral film. Withinobserver error was assessed by re-reading a sample of 194 films at 3 weeks; the coefficients of variation for these repeat measurements were: 3·1 % (heart diameter), 1·3'% (transverse thoracic diameter), 3·9% (broad axis), 5'5% (long axis) and 6·8% (horizontal axis). Since heart volume is strongly related to body surface area, the relative heart volume was obtained by dividing heart 860 H. Hemingway et al.
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The Whitehall study follow-up 861 Ca) Figure 1 Radiological measures of heart size. (a) Postero-anterior view; (b) lateral view; 1. heart diameter; 2. transthoracic diameter; 3. long axis of the heart; 4. broad axis of the heart; 5. horizontal axis of the heart.
The cardiothoracic ratio = heart diameter/transverse thoracic diameter. Heart volume = long axis x broad axis x horizontal diameter x (n/ 6 x 46·52)11000000. Relative heart volume = heart volumelbody surface area.
volume by body surface area. Body surface area was calculated using the method of Dubois [32] as weight (kg)0-425 x height (cm)O.75 x 0·007184.
Mortality
Records from 99% of the subjects were identified and flagged at the National Health Service Central Registry who notified us of all deaths up to the end of January 1995 and provided a copy of the death certificate. The men have therefore been followed for a minimum of 25 years, during which time there have been 534 deaths. 
Statistical methods
The study population was divided into five groups of equal size (quintiles) according to the levels of the cardiothoracic ratio and separately for relative heart volume. Although the cardiothoracic ratio and relative heart volume were highly correlated (r=0·6l), all analyses are presented separately. The quintile cutpoints for the cardiothoracic ratio were: 0·40, 0·43, 0-45 and 0·47. The quintile cutpoints for relative heart volume were 351, 384, 419, and 459. Since previous studies have defined a high cardiothoracic ratio as ;?: O· 5 and a high relative heart volume ;?: 500 ml . m -2, we further divided the highest quintile (q5) using these cutpoints.
Thirty-five percent of participants in the top quintile of the cardiothoracic ratio and 44% in the top quintile of relative heart volume satisfied these definitions. Age-adjusted means and proportions were calculated by direct standardization using the total Whitehall study population as the standard. For continuous variables, tests of linear trend in means across the quintile groups were done by assessing the significance of the quintile score in linear regression models with age group as a covariate. For dichotomous variables, the tests of trend in proportions were assessed using Cochran-Mantel-Haenszel tests of association with the quintile groups stratified by age group. Adjusted mortality rate ratios and their confidence intervals were estimated using Cox's proportional hazards regression models. All rate ratios are expressed relative to the lowest quintile (Tables 2 and 4) or tertile  (Table 3 ). All analyses were performed using the statistical package SAS.
Results
The relationship between cardiothoracic ratio and risk factors for coronary heart disease are shown in Table 1 . In general, an increasing heart size was linearly associated with coronary heart disease risk factors, such that those in the highest quintile of heart size had the most adverse age-adjusted mean or highest prevalence of each risk factor. The associations with systolic and diastolic blood pressure were particularly strong. For example comparing the top and bottom quintile of the cardiothoracic ratio, there was a 9·4 mmHg difference in mean systolic blood pressure and a 8·4 mmHg difference in diastolic blood pressure. The risk factor associations were very similar with relative heart volume (data available on request) except that, as anticipated, the cardiothoracic ratio, but not relative heart volume, was Eur Heart J, Vol. 19, June 1998
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*Means and percentages are adjusted for age. Figures in brackets are the standard errors.
associated (inversely) with height-adjusted FEV j and smoking. Lower heart rates were associated with larger heart sizes. Only eight participants (0'7%) had ECG evidence of left ventricular hypertrophy and this was not related to heart size. The relationship between radiographic heart size and age-adjusted mortality rates over the 25 years of follow up is shown in Table 2 . Even though the cardiothoracic ratio and relative heart volume were highly correlated (r=0'6l), each had an independent effect on coronary heart disease mortality, with no evidence of interaction. A cardiothoracic ratio :2: O' 5 was found in 84 (7%) of participants and was associated with an increased risk of mortality from coronary heart disease, stroke and all causes, with rate ratios (95% confidence Eur Heart J, Vol. 19, June 1998 intervals) of 2·59 (1'47-4'57), 2·95 (0'98-8'89) and 1'57 (1'10-2'23) respectively. When participants with a cardiothoracic ratio :2: O' 5 were excluded, the top quintile (cardiothoracic ratio :2: 0·47 and <0, 5) was associated with elevated coronary heart disease risk with an age-adjusted rate ratio of 1·94 (1'16-3'24) . Each quintile of the cardiothoracic ratio above the lowest was associated with increased risk of coronary heart disease (P value for linear trend <0,001). The relative heart volume dichotomized at :2: 500 ml . m -2 (found in 9% of participants) or divided by quintiles, showed similar effects to the cardiothoracic ratio for all-cause, coronary and stroke mortality.
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disease mortality both within the first 10 years of follow-up (56 coronary heart disease deaths) and during the subsequent 15 years (140 coronary heart disease deaths). For example, the age-adjusted rate ratio for the top vs the bottom quintile of the cardiothoracic ratio was 1·98 (0'90-4'36) and 2·22 (1·24-3·96) respectively. The effect of heart size on coronary heart disease deaths occurring before age 70 (n=98 'premature' deaths) was stronger than that for coronary heart disease deaths occurring at age 70 or older (n=98 'non-premature' deaths). For premature coronary heart disease deaths, comparing top vs bottom quintiles, the age-adjusted rate ratio was 2-49 (I. 31-4'72) for cardiothoracic ratio and 2·32 (1'26-4·28) for relative heart volume; the corresponding rate ratios for non-premature coronary heart disease deaths were 1·77 (0'89-3'52) and 1·52 (0,80-2,88) respectively. The lowest quintile of the cardiothoracic ratio was associated with the highest rate of respiratory death, although the confidence intervals for the rate ratios for the other quintiles spanned unity. The cardiothoracic ratio was inversely associated with mortality from malignant diseases; this effect was not attenuated by adjusting for the potential confounding effect of smoking (data not shown).
In order to address the potential mediating or confounding effect of blood pressure, the effect of heart size within tertiles of baseline systolic blood pressure was calculated (Table 3) . Tertiles rather than quintiles of heart size were used to obtain sufficient numbers for meaningful analysis. Within each tertile, adjustment was made for age and systolic and diastolic blood pressure. A high cardiothoracic ratio and relative heart volume were associated with elevated rate ratios for coronary heart disease among those participants whose systolic blood pressure was in the lower two tertiles (less than :s;; 142 mmHg) at baseline. Conversely, the cardiothoracic ratio and relative heart volume did not statistically explain the association between systolic blood pressure and coronary heart disease mortality; adjustment for the radiographic measures attenuated the regression coefficients for the effect of systolic blood pressure on coronary heart disease mortality by 14% (cardiothoracic ratio) and 12% (relative heart volume).
The extent to which the cardiothoracic ratio and relative heart volume affect the risk of coronary mortality independent of other potential confounders is shown in Table 4 . Separate adjustments are made for (i) age, diastolic and systolic blood pressure and additionally (ii) prevalent coronary heart disease, heart rate, cholesterol and smoking. In general these adjustments did not attenuate the associations; indeed the effect for those in the top quintile of relative heart volume was strengthened. When participants with a cardiothoracic ratio ~0'5 were excluded, the top quintile (cardiothoracic ratio ~0'47 and <0'5) was associated with elevated coronary heart disease risk in the age-and blood-pressure adjusted models, with a rate ratio of 1·67 (0'99-2'82).
Eur Heart J, Vol. 19, June 1998 There was one death due to heart failure (ICD 428) and five due to hypertensive disease (ICD401-405).
Discussion
Large heart size, measured by cardiothoracic ratio -a simple measure in widespread clinical use -predicted coronary mortality independent of established coronary heart disease risk factors. This is the first demonstration that the cardiothoracic ratio measured in a healthy, middle-aged population predicts coronary mortality as well as the less specific outcome of cardiovascular mortality which includes stroke. This effect persisted during prolonged follow-up and was not confined to those with conventionally defined 'large' hearts. The relative heart volume, which uses measurements from the lateral as well as the postero-anterior chest X-ray, also predicted coronary heart disease mortality, consistent with the Reykjavik study [33] , but the association was no stronger than with the cardiothoracic ratio and coronary heart disease. The extent to which left ventricular mass and systolic dysfunction -pathophysiological correlates of the cardiothoracic ratio and relative heart volume -are independent risk factors for coronary heart disease should be further investigated.
Larger heart sizes were directly related to adverse levels of other coronary heart disease risk factors, with the important exception of smoking for the cardiothoracic ratio. The relationship with blood pressure was particularly strong but was unlikely to be the sole reason for the relationship between the cardiothoracic ratio and coronary heart disease mortality. In the present study, the relationship was found after adjustment for systolic and diastolic blood pressure and was present within the lower two tertiles of systolic blood pressure, even after adjustment for the potential residual confounding of systolic and diastolic blood pressure within these groups. Furthermore, several lines of evidence suggest that enlargement of the left ventricle reflects more than a time-integrated measure of 'end organ damage' from systolic blood pressure load: detailed characterization of blood pressure (beyond single resting readings) is a weak or inconsistent independent predictor of left ventricular mass in children, adolescents and middle-aged adults [34] , and meta-analyses [35] of trials investigating the regression of left ventricular hypertrophy suggest that the degree of regression is specific for certain pharmacological agents and is unrelated to extent of blood pressure reduction;7 left ventricular mass is itself an independent predictor of subsequent increases in blood pressure [36.37] .
The relative contribution of hypertrophy and dilatation of each cardiac chamber to radiographic measurements of heart size is not clear. However, the cardiothoracic ratio and relative heart volume do represent valid albeit imperfect measures of left ventricular mass and left ventricular systolic dysfunction. Davis et al. examined the relationship between the cardio-disease mortality both within the first 10 years of follow-up (56 coronary heart disease deaths) and during the subsequent 15 years (140 coronary heart disease deaths). For example, the age-adjusted rate ratio for the top vs the bottom quintile of the cardiothoracic ratio was 1·98 (0'90-4'36) and 2·22 (1·24-3·96) respectively. The effect of heart size on coronary heart disease deaths occurring before age 70 (n=98 'premature' deaths) was stronger than that for coronary heart disease deaths occurring at age 70 or older (n=98 'non-premature' deaths). For premature coronary heart disease deaths, comparing top vs bottom quintiles, the age-adjusted rate ratio was 2-49 (I. 31-4'72) for cardiothoracic ratio and 2·32 (1'26-4·28) for relative heart volume; the corresponding rate ratios for non-premature coronary heart disease deaths were 1·77 (0'89-3'52) and 1·52 (0,80-2,88) respectively.
The lowest quintile of the cardiothoracic ratio was associated with the highest rate of respiratory death, although the confidence intervals for the rate ratios for the other quintiles spanned unity. The cardiothoracic ratio was inversely associated with mortality from malignant diseases; this effect was not attenuated by adjusting for the potential confounding effect of smoking (data not shown).
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The relative contribution of hypertrophy and dilatation of each cardiac chamber to radiographic measurements of heart size is not clear. However, the cardiothoracic ratio and relative heart volume do represent valid albeit imperfect measures of left ventricular mass and left ventricular systolic dysfunction. Davis et al. examined the relationship between the cardiothoracic ratio > OA9 and relative heart volume ~ 500 ml . m -2 and left ventricular hypertrophy defined as the upper 2% of ventricular weights in a post-mortem population free of cardiopulmonary disease. Thus defined, the cardiothoracic ratio and relative heart volume had sensitivities of 57% and 65% and specificities of 83% and 80%, respectively, for the detection of left ventricular hypertrophy[9 1 . Using 58 patients with angiographically assessed left ventricular size, Chikos et al. found that relative heart volume was highly correlated (r=0'66) with left ventricular mass[l51. It is well established that the effect of using an imperfect measure of left ventricular mass such as these is to bias the rate ratios towards unity[38 1 .
The cardiothoracic ratio and relative heart volume are also inversely associated with left ventricular ejection fraction [18,191. For example in the V-HeFT trials in patients with chronic heart failure, there was a negative correlation (r= -0·27) between the cardiothoracic ratio and ejection fraction. The mean cardiothoracic ratio was 0·53 and each 5% increment in the cardiothoracic ratio from OAO to 0·70 was associated with reduced survival. This independent prognostic effect of the cardiothoracic ratio was found at each level of ejection fraction, raising the possibility that dilatation of right heart structures (which may indicate duration of left ventricular dysfunction and/or circulatory congestion) are additionally important. Death certification is unhelpful in establishing a role for left ventricular systolic dysfunction; many deaths in patients with heart failure are given coronary heart disease as the underlying cause, either because coronary heart disease was the underlying cause of the heart failure or because the patient dies suddenly and an acute coronary event is assumed.
The cardiothoracic ratio predicted coronary heart disease mortality at least as strongly as the more detailed research measure of relative heart volume and in regression models each measure independently predicted coronary heart disease mortality. However, relative heart volume requires lateral as well as posteroanterior chest X-rays and therefore entails a higher cost and a substantial additional radiation exposure. Previous studies have not compared the extent to which the additional information contained in relative heart volume is a better predictor of coronary heart disease events than the cardiothoracic ratio.
Unlike relative heart volume, the cardiothoracic ratio is routinely reported in radiological and cardiological practice with a value of ~0'5 denoting an enlarged heart most commonly due to heart failure and a low cardiothoracic ratio being associated with the pulmonary hyper-inflation of chronic obstructive airways disease. We have demonstrated that a cardiothoracic ratio within a range conventionally considered 'normal' (cardiothoracic ratio ~0'47 and <0'5) was associated with elevated risk of coronary and cardiovascular mortality. The cutpoint of ~ O' 5 was originally proposed on statistical[l3,39 1 , not prognostic, grounds to identify the mean +2 SD (i.e. the top 2'5%) of the cardiothoracic has not yet been established that reductions in markers of heart size lead to reductions in subsequent coronary heart disease events. Further studies are required to investigate whether such intermediate endpoints are worthwhile therapeutic goals. Among patients with high relative heart volume, serum cholesterol, blood pressure and smoking are prognostic factors[50 1 , suggesting additional areas for intervention. Echocardiography, more costly than radiography, is unsuccessful in up to 30% of patients, particularly the elderly and obese. Although the cost benefit of routine chest X-rays in cardiological practice has been questioned[51 1 a continued role as part of risk stratification appears justified.
The potential public health importance of preventing raised heart size is further suggested by the strength and persistence of its effect. The magnitude of the association of cardiothoracic ratio with coronary heart disease is comparable to that for systolic or diastolic blood pressure or cholesterol; age-adjusted rate ratios comparing top and bottom quintiles of each exposure being 2·15 (1. 35-3A4), 2·40 (2·13-2,72) and 1·92 (1'70-2'17) respectively (using all Whitehall participants). Furthermore, the elevated risk of coronary heart disease associated with cardiothoracic ratio and relative heart volume was found both in the first 10 years and the Eur Heart J, Vol. 19, June 1998 thoracic ratio > OA9 and relative heart volume ~ 500 ml . m -2 and left ventricular hypertrophy defined as the upper 2% of ventricular weights in a post-mortem population free of cardiopulmonary disease. Thus defined, the cardiothoracic ratio and relative heart volume had sensitivities of 57% and 65% and specificities of 83% and 80%, respectively, for the detection of left ventricular hypertrophy[9 1 . Using 58 patients with angiographically assessed left ventricular size, Chikos et al. found that relative heart volume was highly correlated (r=0'66) with left ventricular mass[l51. It is well established that the effect of using an imperfect measure of left ventricular mass such as these is to bias the rate ratios towards unity[38 1 .
The cardiothoracic ratio and relative heart volume are also inversely associated with left ventricular ejection fraction [18, 191 . For example in the V-HeFT trials in patients with chronic heart failure, there was a negative correlation (r= -0·27) between the cardiothoracic ratio and ejection fraction. The mean cardiothoracic ratio was 0·53 and each 5% increment in the cardiothoracic ratio from OAO to 0·70 was associated with reduced survival. This independent prognostic effect of the cardiothoracic ratio was found at each level of ejection fraction, raising the possibility that dilatation of right heart structures (which may indicate duration of left ventricular dysfunction and/or circulatory congestion) are additionally important. Death certification is unhelpful in establishing a role for left ventricular systolic dysfunction; many deaths in patients with heart failure are given coronary heart disease as the underlying cause, either because coronary heart disease was the underlying cause of the heart failure or because the patient dies suddenly and an acute coronary event is assumed.
Unlike relative heart volume, the cardiothoracic ratio is routinely reported in radiological and cardiological practice with a value of ~0'5 denoting an enlarged heart most commonly due to heart failure and a low cardiothoracic ratio being associated with the pulmonary hyper-inflation of chronic obstructive airways disease. We have demonstrated that a cardiothoracic ratio within a range conventionally considered 'normal' (cardiothoracic ratio ~0'47 and <0'5) was associated with elevated risk of coronary and cardiovascular mortality. The cutpoint of ~ O' 5 was originally proposed on statistical[l3,39 1 , not prognostic, grounds to identify the mean +2 SD (i.e. the top 2'5%) of the cardiothoracic
The Whitehall study follow-up 867 ratio distribution in healthy populations; however, using this cutpoint, an elevated cardiothoracic ratio was found in 7% of the present study and 20% of white men in NHANES-I[161. Furthermore in the SOLVD Prevention trial, 60% of asymptomatic patients with ejection fractions S 35% had a cardiothoracic ratio of <0, 5[401.
Several interrelated aetiological mechanisms linking enlarged hearts with coronary mortality have been proposed. First, increased left ventricular mass increases myocardial oxygen demand while reducing coronary blood flow reserve[ 41 1. Thus for any degree of coronary artery stenosis, the consequences are more severe for those with higher left ventricular mass[ 42 1. Second, increased left ventricular mass is associated with the risk of fatal ventricular arrhythmias[43 1 . Third, it is likely that both raised left ventricular mass and atherothrombotic disease of the coronary arteries share common antecedents; these include obesity and insulin resistance [44, 45 1 . Endothelial dysfunction, an early marker of atherosclerotic disease, is also associated with raised left ventricular mass [ 46 1 .
If a higher cardiothoracic ratio is associated with elevated coronary heart disease risk, does lowering the cardiothoracic ratio reduce risk? Drug treatment of hypertension leads to a reduction in the cardiothoracic ratio[ 47 1 and ACE inhibitors in severe heart failure may reduce relative heart volume[ 48 1. Exercise among those with hypertension leads to a lowering of left ventricular mass[ 49 1. The reversibility of left ventricular mass is not only of therapeutic importance but may also help elucidate mechanisms governing increases in left ventricular mass. Thus anti-hypertensive agents are not uniform in their ability to lower left ventricular mass and a specific role for ACE inhibition has been proposed[35 1 . Crucially it has not yet been established that reductions in markers of heart size lead to reductions in subsequent coronary heart disease events. Further studies are required to investigate whether such intermediate endpoints are worthwhile therapeutic goals. Among patients with high relative heart volume, serum cholesterol, blood pressure and smoking are prognostic factors[50 1 , suggesting additional areas for intervention. Echocardiography, more costly than radiography, is unsuccessful in up to 30% of patients, particularly the elderly and obese. Although the cost benefit of routine chest X-rays in cardiological practice has been questioned[51 1 a continued role as part of risk stratification appears justified.
The potential public health importance of preventing raised heart size is further suggested by the strength and persistence of its effect. The magnitude of the association of cardiothoracic ratio with coronary heart disease is comparable to that for systolic or diastolic blood pressure or cholesterol; age-adjusted rate ratios comparing top and bottom quintiles of each exposure being 2·15 (1. 35-3A4), 2·40 (2·13-2,72) and 1·92 (1'70-2'17) respectively (using all Whitehall participants). Furthermore, the elevated risk of coronary heart disease associated with cardiothoracic ratio and relative heart volume was found both in the first 10 years and the subsequent 15 years of follow up. The indentification of modifiable environmental and biological determinants of left ventricular mass in healthy populations will help to inform such preventive effects [34, 45, 52 , 53 1. The cardiothoracic ratio predicts coronary heart disease mortality over 25 years of follow-up in middleaged men. This effect is not confined to those with conventionally defined large hearts and is independent of established coronary heart disease risk factors. Although effective interventions exist to lower heart size, it is not yet known whether this constitutes a legitimate therapeutic goal. Population-based echocardiographic studies are required to elucidate these results and build on an endeavour begun 102 years ago[54 1 The cardiothoracic ratio predicts coronary heart disease mortality over 25 years of follow-up in middleaged men. This effect is not confined to those with conventionally defined large hearts and is independent of established coronary heart disease risk factors. Although effective interventions exist to lower heart size, it is not yet known whether this constitutes a legitimate therapeutic goal. Population-based echocardiographic studies are required to elucidate these results and build on an endeavour begun 102 years ago[54 1 • M.M. is supported by an MRC Research Professorship. M.S. is supported by the British Heart Foundation. We gratefully acknowledge the comments of the anonymous referee.
